nialamide has been researched along with Blood Coagulation Disorders in 2 studies
Nialamide: An MAO inhibitor that is used as an antidepressive agent.
Blood Coagulation Disorders: Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Nicola, P | 2 |
2 other studies available for nialamide and Blood Coagulation Disorders
| Article | Year |
|---|---|
[Prevention of thrombophilic states by prolonged activation of fibrinolysis].
Topics: Acetates; Animals; Anticholesteremic Agents; Blood Coagulation Disorders; Butyrates; Fibrinolytic Ag | 1967 |
[Long-acting fibrinolytic drugs. Drugs acting on platelet aggregation].
Topics: Acetates; Animals; Blood Coagulation Disorders; Blood Platelet Disorders; Blood Platelets; Delayed-A | 1967 |